GE HealthCare enters $750M term loan and issues $1.25B notes to fund Intelerad acquisition

GE HealthCare Technologies Inc.

Term loan credit facility of $750 million, three-year, unsecured, with JPMorgan as administrative agent.
Issued $600M 4.150% Senior Notes due 2028 and $650M 4.950% Senior Notes due 2035.
Proceeds from notes, term loan, and cash on hand to pay purchase price for Intelerad Medical Systems.
Term loan interest based on base rate or SOFR plus margin tied to credit ratings; contains leverage covenant.
Notes are senior unsecured and rank equally with other unsecured debt.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

GE HealthCare Technologies Inc. incurred term loan of $750 million with JPMorgan Chase Bank, N.A., as administrative agent maturing third anniversary.

Instrument: term loan
Principal: $750 million
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Maturity: third anniversary
Event: incurrence

Exact text from the filing

On December 12, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into a three-year senior unsecured term loan credit facility (the “Term Loan Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein. Pursuant to the Term Loan Credit Agreement, the lenders thereunder have committed to make an unsecured term loan in an aggregate amount of $750 million (the “Term Loan”), which will be made in a single borrowing on a future date subject to the satisfaction (or waiver) of certain customary conditions precedent, and will mature and be payable in full on the third anniversary thereof.

View on SEC.gov

311 debt financings filed in the last 30 days. Browse all debt financings →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-319383

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.